CLGM
TARS icon

Capitolis Liquid Global Markets’s Tarsus Pharmaceuticals TARS Stock Holding History

Capitolis Liquid Global Markets’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-102,600
Closed -$6.1M – 363
2025
Q3 		$6.1M Sell
102,600
-139,500
-58% -$6.87M 0.05% 170
2025
Q2 		$9.81M Buy
+242,100
New +$10.9M 0.07% 139

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Capitolis Liquid Global Markets's TARS Position: Q4 2025 in Review

Capitolis Liquid Global Markets sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 102,600 shares — an estimated $6.1M sold.

Capitolis Liquid Global Markets first reported a position in TARS in Q2 2025 and held it in 2 quarters. The position peaked at $9.81M in Q2 2025. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • Capitolis Liquid Global Markets reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Capitolis Liquid Global Markets sold 102,600 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $6.1M.
  • Capitolis Liquid Global Markets first reported a position in Tarsus Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Capitolis Liquid Global Markets's Tarsus Pharmaceuticals position peaked at $9.81M in Q2 2025.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Capitolis Liquid Global Markets's 13F filing for Q4 2025, filed 17 Feb 2026.